OR WAIT null SECS
Click here to read the articles and view the interactive digital edition
Despite the ongoing turmoil over tariffs, medicine costs, and FDA policy, US wholesalers are performing well.
From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment explores how disciplined governance and forward-thinking models can safeguard profitability in a volatile market.
As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate discounts, and limited transparency.
June 20, 2025
In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing the strategies that are most effective in ensuring resilience across the global supply chain.
The new system meets the increasing demand for faster, more precise processes that enhance quality while boosting efficiency in the pharma manufacturing industry.
June 19, 2025
A cross-sectional study investigates whether becoming eligible for Medicare at age 65 is linked to changes in healthcare use among individuals experiencing mental health challenges.
In the third part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, explains how a flat admin fee model can potentially create more value for both payers and patients.
June 18, 2025
Is Medicare plan switching influenced by initial type of Medicare coverage and cancer history?
The 200,000 square-foot Madison, WI facility will serve as the flagship location, with capabilities for future growth.
The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.
In the second part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, discusses how this MFN executive order can affect players in the space that operate under a rebate-driven PBM model.